Most Recent
Novartis, Pharmacor resolve suit over Gilenya patents
Intellectual Property 2022-11-14 1:42 pm By Cat Fredenburgh

Novartis and and generic drug maker Pharmacor have resolved litigation over the Swiss pharmaceutical giant’s patents for blockbuster MS drug Gilenya.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sanofi challenges Amgen’s patents for cholesterol-lowering antibodies
Intellectual Property 2022-10-18 5:23 pm By Sam Matthews

French drug giant Sanofi has appealed a decision giving American biopharmaceutical company Amgen the go-ahead for its patents for a cholesterol-lowering antibody that could be used to treat heart disease, diabetes, stroke and Alzheimer’s.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Court finds Globaltech, Boart Longyear infringed mining patent
Intellectual Property 2022-10-10 11:50 pm By Cindy Cameronne

A judge has found mining tool company Globaltech and mineral exploration company Boart Longyear infringed a patent for a mining tool owned by Australian Mud Company.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Full Court upholds validity of Pfizer’s Dynastat patent
Intellectual Property 2022-09-30 4:58 pm By Cindy Cameronne

A judge has thrown out competing appeals of a decision finding Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

No jackpot for Aristocrat, with High Court split on computer-implemented inventions
High Court 2022-08-17 11:12 pm By Cindy Cameronne

Gaming giant Aristocrat Technologies has lost its legal challenge to a decision that rejected a patent for its popular Lightning Link electronic poker machine, after six High Court Justices were equally split on whether it could be patented.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Drug companies drop bid for ACCC approval of Revlimid patent settlement
Competition & Consumer Protection 2022-07-29 11:44 am By Cat Fredenburgh

Bristol-Myers Squibb unit Celgene and two generic drug makers have withdrawn an application for ACCC approval of a patent settlement that would have allowed for an early launch of a generic version of blockbuster cancer drug Revlimid.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bayer wants to amend Xarelto patent at centre of Sandoz’s invalidity claim
Intellectual Property 2022-07-15 11:37 am By Christine Caulfield

German pharmaceutical giant Bayer, which is facing a legal bid by generic drug maker Sandoz to invalidate patents covering blood clot drug Xarelto, is seeking to amend one of the patents in dispute.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Confidentiality no ‘excuse’ for Apple refusing to hand over docs in patent dispute, court told
Intellectual Property 2022-06-24 5:25 pm By Cindy Cameronne

An Australian non-practicing entity alleging Apple’s Touch ID and Face ID technology infringes its patents has accused the Silicon Valley company of refusing to comply with court orders to hand over documents.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Full Court shoots down Boehringer opposition to Merck Sharp & Dohme’s parasite patent
Intellectual Property 2022-05-19 3:38 pm By Cat Fredenburgh

The Full Federal Court has rejected German drug maker Boehringer Ingelheim’s appeal of ruling that shot down its opposition to Merck Sharp & Dohme’s patent application for an injectable anti-parasite drug for livestock.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

High Court KOs Repipe’s fight over patents for computer-implemented tech
Intellectual Property 2022-05-11 1:12 pm By Christine Caulfield

The High Court has rejected plumbing company Repipe’s application to hear its case centred on the question of patent eligibility for computer-implemented inventions, saying the case was not an appropriate vehicle for special leave.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?